Tag.bio
San Francisco
About Tag.bio
Tag.bio enables organizations to securely derive insights using data-as-products in a data mesh architecture. Customers use Tag.bio’s data science platform to discover, share, and unite diverse siloed data sets and execute workloads using no-code/low-code data mesh framework. The data science platform (available in AWS and Azure Marketplaces) combines data sets, smart APIs, statistical and machine learning algorithms into data products (application layer) for users to discover insights via apps and/or GenAI solutions. Learn more at https://tag.bio.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $50.0K
- Funding stage: Seed
- Last round: Non-Equity Assistance (Dec 2021)
- Website: tag.bio
- Phone: 4158949894
Industries & Categories
Analytics, Artificial Intelligence (AI), Big Data, Clinical Trials, Cloud Data Services
Social Profiles
Canonical: https://fsome.com/organization/tag-bio-78664 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.